Patent details
EP3579840
Title:
TREATMENT OF CANCER AND INHIBITION OF METASTASIS
Basic Information
- Publication number:
- EP3579840
- PCT Application Number:
- EP2018053457
- Type:
- European Patent Granted for LU
- Legal Status:
- Unitary Effect Registered
- Application number:
- EP187045554
- PCT Publication Number:
- WO2018146313
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- TREATMENT OF CANCER AND INHIBITION OF METASTASIS
- French Title of Invention:
- TRAITEMENT DU CANCER ET SUPPRESSION DES MÉTASTASES
- German Title of Invention:
- BEHANDLUNG VON KREBS UND HEMMUNG VON METASTASEN
- SPC Number:
-
Unitary Effect
- Unitary Effect Requested:
- Yes
- Unitary Effect Request Filing Date:
- 27/06/2023
- Link to UPP Register:
-
European Patent Register
- Unitary Effect Request Withdrawal Date:
-
- Unitary Effect Status:
- Unitary Effect Registered
- Unitary Effect Acceptance Decision Date:
- 03/07/2023
- Unitary Effect Rejection Decision Date:
-
- Unitary Effect Date:
- 07/06/2023
- Unitary Effect Registration Date:
- 03/07/2023
- Unitary Effect Re-establishment of rights Filing Date:
-
- Unitary Effect Re-establishment of rights EPO Decision :
-
- Unitary Effect Re-establishment of rights EPO Decision Date:
-
- Explanatory Text UE:
-
- Safety Net Request Date:
- Safety Net Decision Date:
- Safety Net Decision Outcome:
- SPC Number:
-
Dates
- Filing date:
- 12/02/2018
- Grant date:
- 07/06/2023
- EP Publication Date:
- 18/12/2019
- PCT Publication Date:
- 16/08/2018
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 07/06/2023
- EP B1 Publication Date:
- 07/06/2023
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 12/02/2038
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 11/08/2023
-
-
- Name:
- Celex Oncology Innovations Limited
- Address:
- 101 New Cavendish Street, London W1W 6XH, United Kingdom (GB)
History of Owners
- From:
- 31/05/2023
- To:
- 11/08/2023
- Name:
- Celex Oncology Innovations Limited
- Address:
- 64 New Cavendish Street, London W1G 8TB, United Kingdom (GB)
Inventor
1
- Name:
- JENSEN, Leif Helth
- Address:
- Switzerland (CH)
2
- Name:
- FALTUM, Carsten
- Address:
- Switzerland (CH)
3
- Name:
- DJAMGOZ, Mustafa
- Address:
- United Kingdom (GB)
Priority
- Priority Number:
- PA201770091
- Priority Date:
- 10/02/2017
- Priority Country:
- Denmark (DK)
Classification
- IPC classification:
-
A61K 31/553;
A61P 35/04;
Publication
European Patent Bulletin
1
- Issue number:
- 202323
- Publication date:
- 07/06/2023
- Description:
- Grant (B1)
2
- Issue number:
- 202331
- Publication date:
- 02/08/2023
- Description:
- Unitary Effect Request Receipt
3
- Issue number:
- 202331
- Publication date:
- 02/08/2023
- Description:
- Unitary Effect Request Acceptance
4
- Issue number:
- 202337
- Publication date:
- 13/09/2023
- Description:
- Change of owner's name or address
Annual Fees
- Annual Fee Due Date:
-
- Annual Fee Number:
-
- Expected Payer:
-
- Last Annual Fee Payment Date:
-
- Last Annual Fee Paid Number:
-
- Payer:
-
Filing date |
Document type |
Number of pages |